Tiziana life sciences highlighted in forbes article

Article entitled "new t cell antibody treatment improves outcomes for covid patients" reviews the company's first in class foralumab, a unique intranasal monoclonal antibody designed to treat multiple sclerosis and a range of other neurodegenerative diseases article entitled "new t cell antibody treatment improves outcomes for covid patients" reviews the company's first in class foralumab, a unique intranasal monoclonal antibody designed to treat multiple sclerosis and a range of other neurodegenerative diseases
TLSA Ratings Summary
TLSA Quant Ranking